生活方式和血压对中风的相互作用:来自中国北方的一项横截面研究
Jiantao Yu1, Qiang Zhou2, Yanyan Zhao3
1Hebei Medical, University Second Hospital, Shijiazhuang, China.
PloS one
|March 9, 2026
概括
高血压和不健康的生活方式显著增加了老年人的中风风险. 结合起来,这些因素协同提高中风发病率,强调需要综合预防策略.
科学领域:
- 老年学与公共卫生
- 心血管流行病学心血管流行病学
- 预防医学 预防医学
背景情况:
- 卒中仍然是65岁以上成年人残疾和死亡的主要原因之一.
- 了解生活方式,血压和中风风险之间的相互作用对于有效的预防至关重要.
研究的目的:
- 量化生活方式因素和血压对65岁及以上成年人中风风险的相互作用.
- 为临床医生提供针对性中风预防策略的多因素风险因素的信息.
主要方法:
- 用分层集群随机抽样分析中国北部2019年健康检查记录.
- 根据血压水平 (心压和腹压) 对参与者的分类.
- 应用后勤回归与乘法相互作用模型来评估生活方式和血压对中风发病率的综合影响.
主要成果:
- 总共分析了34,995名参与者 (平均年龄为71.9岁).
- 压缩和压缩血压升高与中风发病率有显著的线性正相关性 (Ptrend < 0.001).
- 不健康的生活方式因素协同增加了中风风险,并与血压升高结合.
结论:
- 压缩性和压缩性血压升高独立地与中风发病率的增加有关.
- 在不健康的生活方式 (吸烟,酒精,肥胖,不活动) 和高血压之间存在协同作用,提高中风风险.
- 建议针对血压和可修改的生活方式因素的综合策略用于预防中风.
相关概念视频
Hypertension IV: Drug Therapy and Lifestyle Modifications
800
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
800
Factors affecting Blood pressure
7.5K
Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
Physiological Factors:
7.5K
Hypertension II: Pathophysiology
1.3K
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.3K
Hypertension III: Clinical Manifestations and Diagnostic Studies
690
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
690
Hypertension I: Introduction
1.1K
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
1.1K
Atherosclerosis III: Management
541
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
541

